← Eichor
Condition: Progression Of Bladder Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Progression Of Bladder Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07025174Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06170177Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer
Phase N/A · 1 location(s) · Zhilong Dong · NCT07424560A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscl
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06733363Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Phase N/A · 1 location(s) · Zhiping Wang · NCT07589413Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Phase 2 · 1 location(s) · Michael A. O'Donnell · NCT07322263Prospective Sample Collection for Cancer of Bladder
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT03973671Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · 163 location(s) · Bristol-Myers Squibb · NCT07106762
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.